Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 319 for “"Acinetobacter baumannii"”.
-
Acinetobacter baumannii patogenezės molekuliniai mechanizmai /
… agents, the highest resistance is observed among Acinetobacter baumannii strains. This doctoral thesis is aimed to characterise A. baumannii strains, isolated in Lithuanian hospitals, for the various phenotypes related to virulence. Studies have shown that strains belonging to the predominant …
-
Novel Therapy for Acinetobacter baumannii Infections
… United States and 35,000 people die as a result. Acinetobacter baumannii is one of these antibiotic-resistant pathogens and has become multi-drug resistant in recent years. This bacterium typically causes infection within the blood, urinary tract, or lungs and is commonly spread within a hospital …
-
Molecular mechanisms of Acinetobacter baumannii pathogenesis /
… agents, the highest resistance is observed among Acinetobacter baumannii strains. This doctoral thesis is aimed to characterise A. baumannii strains, isolated in Lithuanian hospitals, for the various phenotypes related to virulence. Studies have shown that strains belonging to the predominant …
-
tRNA Methyltransferases Mediate Acinetobacter baumannii Pathobiology
… largely unknown. The Gram-negative pathogen Acinetobacter baumannii is currently acquiring multi-drug resistance at alarming rates. A. baumannii is also incredibly capable of surviving a wide range of stressors, to the extent that our understanding of its pathogenesis relies on its ability to …
-
Transposition of ISAba13 in Acinetobacter baumannii AB5075
Acinetobacter baumannii is a critical priority category pathogen for which new drug treatments are urgently required. A major cause of nosocomial infection, A. baumannii is able to colonise and persist for long periods of time in hospital environments. Here we have characterised a novel colony …
-
Lysin Based Antimicrobial Peptides Against Acinetobacter Baumannii
Acinetobacter baumannii is a Gram-negative bacterial pathogen responsible for a range of nosocomial infections. The recent rise and spread of multidrug resistant A. baumannii clones has fueled a search for alternative therapies, including bacteriophage endolysins with potent antibacterial …
-
Synthesis of an Acinetobacter Baumannii Lipooligosaccharide Subunit
Acinetobacter baumannii is a Gram-negative, multi drug-resistant bacterium that was placed on the World Health Organization’s watchlist of drug-resistant bacteria. A. baumannii is an ESKAPE pathogen, one of six increasingly antimicrobial-resistant bacteria that are responsible for nosocomial …
-
Γονιδιωματική ανάλυση παθογόνων στελεχών του Acinetobacter baumannii
… ανάλυση τριών κλινικών στελεχών του βακτηρίου A. baumannii (5939, 5972 και J_5) σε συνδυασμό με το πρότυπο στέλεχος αναφοράς ATCC 19606. Τα στελέχη αλληλουχήθηκαν μέσω υβριδικής προσέγγισης που συνδύασε τεχνολογίες αλληλούχισης μακρών και βραχέων αναγνώσεων, επιτυγχάνοντας γονιδιώματα υψηλής …
-
Mobilome and antibiotic resistance in Acinetobacter baumannii
Acinetobacter baumannii is an important microorganism involved in hospital-acquired infections with a remarkable ability to develop resistance to multiple antibiotics (multidrug-resistance, MDR) which makes it a highly troublesome pathogen in many hospitals around the world. Third-generation …
-
Diversity of acinetobacter baumannii isolates from Egypt
Acinetobacter baumannii is an important nosocomial pathogen, frequently associated with morbidity and mortality in immunocompromised patients due to the immuno-ablative treatments, neutropenia and prolonged hospitalization. The ability of A. baumannii to survive in the healthcare setting makes it a …
-
Colistin for multidrug-resistant Acinetobacter baumannii from Thailand
Multidrug-resistant (MDR) Acinetobacter baumannii have caused nosocomial infections worldwide. Nowadays, there are no effective regimens to treat MDR- A. baumannii. Therefore, this study’s objective was to find out an effective antimicrobial combination against MDR-A. baumannii. This project …
-
Characterization of two component systems of Acinetobacter baumannii.
Acinetobacter baumannii is an important opportunistic pathogen of hospital acquired infection, particularly in intensive care units. The emergence and rapid spread of multidrug-resistant A. baumannii strains has become a major health threat worldwide which severely limits the treatment options for …
-
Resistenzmechanismen von Acinetobacter baumannii - Immunologische und PCR- Testung
Infektionen mit Acinetobacter baumannii (A. baumannii) stellen eine große Herausforderung im nosokomialen Umfeld dar. Zum einen sind hauptsächlich Patienten mit schweren Grunderkrankungen von Infektionen betroffen und zum anderen ist A. baumannii in der Lage, eine Vielzahl von Resistenzen zu …
-
Integration of omics and bioinformatics to identify new therapeutic targets for Acinetobacter baumannii. Virulence role of CarO in Acinetobacter baumannii infections
Acinetobacter baumannii remains a significant and difficult-to-treat pathogen that causes a range of interactions with the human host from asymptomatic colonization and carriage in the skin, intestinal tract, and respiratory tract to invasive infection, such as nosocomial pneumonia or bacteraemia. …
-
Molecular and functional typing of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with emphasis on multi-drug resistant Acinetobacter baumannii
… leaving few therapeutic options. Among these, Acinetobacter (A.) baumannii is of increasing importance, especially with regard to the epidemic clonal lineages IC I-III, which are particularly associated with carbapenem and multi-drug resistance. Moreover, these clonal lineages could already be …
-
Environmental determinants of antibiotic resistance and virulence of Acinetobacter baumannii and development of novel molecular tools for genetic manipulations of Acinetobacter baumannii
Acinetobacter baumannii is a notorious pathogen in health- care settings around the world, primarily due to its reduced susceptibility to antibiotics. A. baumanniiIt also shows impressive capabilities to adapt to harsh conditions in clinical settings, which contributes to its persistence in such …
-
Mėlynosios šviesos ir gentamicino poveikis Acinetobacter baumannii klinikiniams izoliatams /
Acinetobacter baumannii is an opportunistic pathogen prevalent in clinical settings that infects immunocompromised patients. In cases of infection, patient mortality increases by 40 %, which is why the WHO has classified A. baumannii as a critically crucial pathogenic bacterium, therefore the …
-
Acinetobacter baumannii atsparumo biocidams genų ir fenotipinių savybių tyrimai /
Acinetobacter baumannii is one of the most important nosocomial pathogens, characterized by its ability to survive under unfavorable environmental conditions, form biofilms and develop resistance to various antimicrobial agents. The aim of this study was to investigate A. baumannii biocide …
Page 1 of 16